Abstract
Amiodarone, an anti-arrhythmic drug that contains 39% iodine, is rarely known to cause negative effects on fetal thyroid function after gestational exposure, when given orally to a pregnant woman. Two cases of fetal hypothyroidism after gestational exposure to amiodarone by direct fetal intravenous route are described here.
MeSH terms
-
Adult
-
Amiodarone / administration & dosage
-
Amiodarone / adverse effects*
-
Amiodarone / therapeutic use
-
Anti-Arrhythmia Agents / administration & dosage
-
Anti-Arrhythmia Agents / adverse effects*
-
Anti-Arrhythmia Agents / therapeutic use
-
Female
-
Fetal Diseases / chemically induced*
-
Fetal Diseases / drug therapy*
-
Humans
-
Hypothyroidism / chemically induced*
-
Hypothyroidism / drug therapy
-
Infant, Newborn
-
Injections, Intravenous
-
Male
-
Pregnancy
-
Tachycardia, Supraventricular / drug therapy*
-
Thyroxine / therapeutic use
-
Time Factors
Substances
-
Anti-Arrhythmia Agents
-
Amiodarone
-
Thyroxine